Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Diallo

Showing results (471-480 of 485) with videos related to

Pageof 49
Sort By:
Lancet (London, England)|November 6, 2012
Effect of the Affordable Medicines Facility--malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey dataSarah Tougher, , Yazoume Ye, et al.
The American Journal of Tropical Medicine and Hygiene|July 16, 2024
Effect of Adding a Six-Week Course of Doxycycline to Intensive Hygiene-Based Care for Improving Lymphedema in a Rural Setting of Mali: A Double-Blind, Randomized Controlled 24-Month TrialYaya I Coulibaly, Abdoul F Diabate, Moussa Sangare, et al.
The Journal of Infection|August 31, 2024
Children with hemoglobin C or S trait have low serologic responses to a subset of malaria variant surface antigensRachel D Bailey, Jonathan G Lawton, Amadou Niangaly, et al.
Malaria Journal|September 1, 2016
Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in BandiagaraMahamadou A Thera, Drissa Coulibaly, Abdoulaye K Kone, et al.
Emerging Infectious Diseases|December 21, 2021
Intercontinental Spread of Eurasian Highly Pathogenic Avian Influenza A(H5N1) to SenegalFatou T Lo, Bianca Zecchin, Alpha A Diallo, et al.
Plos One|January 24, 2008
Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trialMahamadou A Thera, Ogobara K Doumbo, Drissa Coulibaly, et al.
Plos One|February 9, 2010
Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trialMahamadou A Thera, Ogobara K Doumbo, Drissa Coulibaly, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 13, 2025
Vaccination strategies for Ebola in the democratic republic of Congo: the WHO-Ebola modeling collaborationMarco Ajelli, Jean-Jacques Muyembe, Alhassane Touré, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2018
Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT studyR Anty, G Favre, A Coilly, et al.
Plos One|November 22, 2013
Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trialMatthew B Laurens, Mahamadou A Thera, Drissa Coulibaly, et al.
Pageof 49

Showing results (471-480 of 485) with videos related to

Sort By:
Pageof 49
Lancet (London, England)|November 6, 2012
Effect of the Affordable Medicines Facility--malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey dataSarah Tougher, , Yazoume Ye, et al.
The American Journal of Tropical Medicine and Hygiene|July 16, 2024
Effect of Adding a Six-Week Course of Doxycycline to Intensive Hygiene-Based Care for Improving Lymphedema in a Rural Setting of Mali: A Double-Blind, Randomized Controlled 24-Month TrialYaya I Coulibaly, Abdoul F Diabate, Moussa Sangare, et al.
The Journal of Infection|August 31, 2024
Children with hemoglobin C or S trait have low serologic responses to a subset of malaria variant surface antigensRachel D Bailey, Jonathan G Lawton, Amadou Niangaly, et al.
Malaria Journal|September 1, 2016
Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in BandiagaraMahamadou A Thera, Drissa Coulibaly, Abdoulaye K Kone, et al.
Emerging Infectious Diseases|December 21, 2021
Intercontinental Spread of Eurasian Highly Pathogenic Avian Influenza A(H5N1) to SenegalFatou T Lo, Bianca Zecchin, Alpha A Diallo, et al.
Plos One|January 24, 2008
Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trialMahamadou A Thera, Ogobara K Doumbo, Drissa Coulibaly, et al.
Plos One|February 9, 2010
Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trialMahamadou A Thera, Ogobara K Doumbo, Drissa Coulibaly, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 13, 2025
Vaccination strategies for Ebola in the democratic republic of Congo: the WHO-Ebola modeling collaborationMarco Ajelli, Jean-Jacques Muyembe, Alhassane Touré, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2018
Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT studyR Anty, G Favre, A Coilly, et al.
Plos One|November 22, 2013
Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trialMatthew B Laurens, Mahamadou A Thera, Drissa Coulibaly, et al.
Pageof 49